Islet Transplantation: An Update

Chang Gung Medical Journal

Volumn 27, Issue 1, 2004, Pages 1-15

  Juang, Jyuhn Huarng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Islet transplantation

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; C PEPTIDE; COMPLEMENT RECEPTOR; CYCLOSPORIN; CYTOKINE RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACLIZUMAB; EXENDIN 4; FINGOLIMOD; GLUCOSE; GLUCOSE TRANSPORTER 2; IMMUNOSUPPRESSIVE AGENT; IMMUNOTOXIN; INSULIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; T LYMPHOCYTE RECEPTOR; TACROLIMUS; VASCULOTROPIN;

ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; CHILD; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENCAPSULATION; FETAL TISSUE TRANSPLANTATION; FETUS; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN DONOR; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PHASE 1 CLINICAL TRIAL; REVIEW; STEM CELL; STREPTOZOCIN DIABETES; TISSUE PRESERVATION; XENOTRANSPLANTATION;

DIABETES MELLITUS, TYPE 1; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 1642278591     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Brendel MD, Hering B, Schultz AO, Schultz B, Bretzel RG. International Islet Transplant Registry Newsletter 2001;8:4.
3. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8.
4. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002;51:2148-57.
5. Alexander JW, Vaughn WK. The use of marginal donors for organ transplantation-the influence of donor age on outcome. Transplantation 1991;51:135-41.
6. Juang JH, Hsu BRS, Kao CH, Yao NK. Influence of donor age on mouse islet characteristics and transplantation. Cell Transplant 2001;10:277-84.
7. Hering B, Schultz AO, Schultz B, Geier C, Bretzel RG, Federlin K. International Islet Transplant Registry Newsletter 1995;6:8.
8. Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988;46:457-60.
9. Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, Rajotte RV. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999;8:285-92.
10. Gaber AO, Fraga DW, Callicutt CS, Gerling IC, Sabek OM, Kotb MY. Improved in vivo pancreatic islet function after prolonged in vitro islet culture. Transplantation 2001;72:1730-6.
11. Alejandro R, Caulfield A, Froud T, Ferreira J, Rosenberg L, Al-abdullah IH, Baidal D, Kirlew TJ, Kenyon NS, Ricordi C. Insulin independence following transplantation of cultured human islets. Cell Transplant 2001;10:520.
12. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RL, Jaffe AS, Cryer PE, Hanto DW, Anderson CB, Flye MW. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 1991;51:76-85.
13. Warnock GL, Kneteman NM, Ryan E, Seelis REA, Rabinovitch A, Rajotte RV. Normoglycemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type I (insulin-dependent) diabetes mellitus. Diabetologia 1991;34:55-8.
14. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom C, Andersson A. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994;344:1402-4.
15. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996;97:2119-29.
16. Juang JH, Hsu BRS, Kuo CH, Fu SH, Lee WC, Yao NK. Neonatal porcine pancreas as a source of islet transplantation. Transplant Proc 2001;33:757-8.
17. Patience C, Takeuchi Y, Weiss RA, Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282-6.
18. van der Laan LJ, Lockey C, Griffeth BC, Frasier FS, Wilson CA, Onions DE, Hering BJ, Long Z, Otto E, Torbett BE, Salomon DR. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000;407:90-4.
19. Efrat S, Fusco-DeMane D, Lemberg H, al Emran O, Wang X. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci U S A 1995;92:3576-80.
20. de la Tour D, Halvorsen T, Demeterco C, Tyrberg B, Itkin-Ansari P, Loy M, Yoo SJ, Hao E, Bossie S, Levine F. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 2001;15:476-83.
21. Lee HC, Kim SJ, Kim KS, Shin HC, Yoon JW. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 2000;408:483-8.
22. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, Karasik A. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000;6:568-72.
23. Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, Boylan MO, Wolfe MM, Kieffer TJ. Glucose-dependent insulin release from genetically engineered K cells. Science 2000;290:1959-62.
24. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 2000;6:278-82.
25. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O' Neil JJ. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000;97:7999-8004.
26. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000;49:157-62.
27. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-94.
28. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001;50:1691-7.
29. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003;111:843-50.
30. Juang JH, Bonner-Weir S, Wu Y-J, Weir GC. Beneficial influence of glycemic control upon the growth and function of transplanted islets. Diabetes 1994;43:1334-9.
31. Davalli AM, Scaglia L, Zanger DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function. Diabetes 1996;45:1161-7.
32. Juang JH, Kuo CH, Huang HS. Fate of a small number of islets transplanted into diabetic mice. Transplant Proc 1997;29:2026-7.
33. Juang JH, Hsu BRS, Kuo CH, Huang HS. Timing of insulin therapy for diabetic recipients with islet transplantation. Transplant Proc 1998;30:576-7.
34. Merino JF, Nacher V, Raurell M, Biarnes M, Soler J, Montanya E. Optimal insulin treatment in syngeneic islet transplantation. Cell Transplant 2000;9:11-8.
35. Juang JH, Hsu BRS, Kuo CH, Ueng WN. Beneficial effects of hyperbaric oxygen therapy on islet transplantation. Cell Transplant 2002;11:95-101.
36. Juang JH, Kuo CH, Hsu BRS. Beneficial effects of pentoxiphylline on islet transplantation. Transplant Proc 2000;32:1073-5.
37. Kaufman DB, Gores PF, Field MJ, Farney AC, Gruber SA, Stephanian E, Sutherland DE. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 1994;43:778-83.
38. Juang JH, Hsu BR-S, Kuo CH. 15-Deoxyspergualin protects the islet graft from macrophage-mediated injury. Transplant Proc 2002;34:1458-9.
39. Arita S, Une S, Ohtsuka S, Atiya A, Kasraie A, Shevlin L, Mullen Y. Prevention of primary islet isograft nonfunction in mice with pravastatin. Transplantation 1998;65:1429-33.
40. Hsu BRS, Juang JH, Fu SH, Kuo CH, Lu WT. Reduction in primary nonfunction of syngeneic islet transplants with nordihydroguaiaretic acid, a lipooxygenase inhibitor. Cell Transplant 2001;10:255-62.
41. Juang JH, Kuo CH, Hsu BRS. Effects of vascular endothelial growth factor on the islet isograft. Transplant Proc 2002;34:2690-2.
42. Juang JH, Kuo CH, Hsu BRS. Effect of gliclazide on islet transplantation. Transplant Proc 2002;34:2696-7.
43. Kim SC, Kim TH, We YM, Park HY, Cho KM, Han DJ. Study for improvement of early implantation and long-term graft survival in pancreatic islet cell transplantation by induction of angiogenesis with gene transfection of vascular endothelial growth factor. Transplant Proc 2003;35:486-7.
44. Sigrist S, Mechine-Neuville A, Mandes K, Calenda V, Braun S, Legeay G, Bellocq J-P, Pinget M, Kessler L. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant 2003;12:627-35.
45. Lacy PE. Status of islet cell transplantation. Diabetes Rev 1993;1:76-92.
46. de Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002;45:159-73.
47. Sullivan SJ, Maki T, Borland KM, Mahoney MD, Solomon BA, Muller TE, Monaco AP, Chick WL. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991;252:718-21.
48. Lanza RP, Borland KM, Lodge P, Carretta M, Sullivan SJ, Muller TE, Solomon BA, Maki T, Monaco AP, Chick WL. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 1992;41:886-9.
49. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 1994;43:1167-70.
50. O'Shea GM, Sun AM. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes 1986;35:943-6.
51. Lum ZP, Tai I, Krestow M, Norton J, Vacek I, Sun AM. Prolonged reversal of the diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 1991;40:1511-6.
52. Soon-Shiong P, Feldman E, Nelson R, Heintz R, Yao Q, Yao Z, Zheng T, Merideth N, Skjak-Braek G, Espevik T, Smidsrod O, Sandford P. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci U S A 1993;90:5843-7.
53. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996;98:1417-22.
54. Calafiore R. Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. ASAIO J 1992;38:34-7.
55. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Mendez R, Sandford PA. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994;343:950-1.
56. Klock G, Frank H, Houben R, Zekorn T, Horcher A, Siebers U, Wohrle M, Federlin K, Zimmermann U. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 1994;40:638-43.
57. De Vos P, De Haan B, Wolters GH, Van Schilfgaarde R. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation 1996;62:888-93.
58. De Vos P, Smedema I, Van Goor H, Moes H, Van Zanten J, Netters S, De Leij LF, De Haan A, De Haan BJ. Association between macrophage activation and function of micro-encapsulated rat islets. Diabetologia 2003;46:666-73.
59. Hsu BR, Fu SH, Hsueh C, Tsai JS, Huang YY, Huang HS. 15-Deoxyspergualin attenuates pericapsular cellular infiltration and prolongs survival of alginate-poly-L-lysine-alginate microencapsulated islets. Transplant Proc 1997;29:2158-60.
60. Hsu BR, Chang FH, Juang JH, Huang YY, Fu SH. The rescue effect of 15-deoxyspergualin on intraperitoneal microencapsulated xenoislets. Cell Transplant 1999;8:307-15.
61. Cole DR, Waterfall M, McIntyre M, Baird JD. Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia 1992;35:231-7.
62. Hsu BRS, Chang FH, Fu SH, Huang YY, Juang JH, Huang HS. A bacteria-expressed mouse interleukin-1 receptor antagonist peptide protects alginate-poly-L-lysine-alginate microencapsulated rat islets against suppressive effect of interleukin-1β in vitro. Transplant Proc 1996;28:1961-3.
63. Selawry HP, Whittington K. Extended allograft survival of islets grafted into intra-abdominally placed testis. Diabetes 1984;33:405-6.
64. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990;249:1293-5.
65. Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997;46:317-22.
66. Selawry HP, Kotb M, Herrod HG, Lu ZN. Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site. Transplantation 1991;52:846-50.
67. Ricordi C, Murase N, Rastellini C, Behboo R, Demetris AJ, Starzl TE. Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation. Cell Transplant 1996;5:53-5.
68. Wu T, Levay-Young B, Heuss N, Sozen H, Kirchhof N, Sutherland DE, Hering B, Guo Z. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 2002;74:22-7.
69. Li H, Ricordi C, Inverardi L. Effects of graft-versus-host reaction on intrahepatic islet transplants. Diabetes 1999;48:2292-9.
70. Kenyon NS, Chatzipetrou M, Masetti M, Ranuncoli A, Oliveira M, Wagner JL, Kirk AD, Harlan DM, Burkly LC, Ricordi C. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999;96:8132-7.
71. Kenyon NS, Fernandez LA, Lehmann R, Masetti M, Ranuncoli A, Chatzipetrou M, Iaria G, Han D, Wagner JL, Ruiz P, Berho M, Inverardi L, Alejandro R, Mintz DH, Kirk AD, Harlan DM, Burkly LC, Ricordi C. Longterm survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 1999;48:1473-81.
72. Levisetti MG, Padrid PA, Szot GL, Mittal N, Meehan SM, Wardrip CL, Gray GS, Bruce DS, Thistlethwaite JR Jr, Bluestone JA. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol 1997;159:5187-91.
73. Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, Kenyon NS, Ricordi C, Burkly LC, Inverardi L. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Diabetes 2001;50:270-6.
74. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995;181:1145-55.
75. Adams AB, Shirasugi N, Durham MM, Strobert E, Anderson D, Rees P, Cowan S, Xu H, Blinder Y, Cheung M, Hollenbaugh D, Kenyon NS, Pearson TC, Larsen CP. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 2002;51:265-70.
76. Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Onodera H, Lazarovits AI, Basadonna GP. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation 1997;63:1355-8.
77. Basadonna GP, Auersvald L, Khuong CQ, Zheng XX, Kashio N, Zekzer D, Minozzo M, Qian H, Visser L, Diepstra A, Lazarovits AI, Poppema S, Strom TB, Rothstein DM. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci U S A 1998;95:3821-6.
78. Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Ricordi C, Rothstein DM, Basadonna GP, Inverardi L. Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes 2003;52:957-64.
79. Woodle ES, Xu D. Zivin RA, Auger J, Charette J, O' Laughlin R, Peace D, Jollife LK, Haverty T, Bluestone JA, Thistlethwaite JR Jr. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1 (Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 1999;68:608-16.
80. Maeda A, Goto M, Zhang J, Bennet W, Groth CG, Korsgren O, Wennberg L. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats. Transplantation 2003;75:1409-14.
81. Fu F, Hu S, Deleo J, Li S, Hopf C, Hoover J, Wang S, Brinkmann V, Lake P, Shi VC. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720. Transplantation 2002;73:1425-30.
82. Bennet W, Sundberg B, Lundgren T, Tibell A, Groth CG, Richards A, White DJ, Elgue G, Larsson R, Nilsson B, Korsgren O. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000;69:711-9.
83. Ferrari-Lacraz S, Zheng XX, Kim YS, Li Y, Maslinski W, Li XC, Strom TB. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 2001;167:3478-85.
84. Li XC, Ima A, Li Y, Zheng XX, Malek TR, Strom TB. Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival. J Immunol 2000;164:1193-9.
85. Feng X, Zheng XX, Yi S, Lehnert AM, Strom TB, O'Connell PJ. IL-10/Fc inhibits macrophage function and prolongs pancreatic islet xenograft survival. Transplantation 1999;68:1775-83.
86. Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T, Wasserfall C, Goudy K, Zahr E, Poggioli R, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick H, Flotte T, Ellis TM, Ricordi C, Inverardi L, Atkinson MA. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 2003;52:708-16.
87. Thomas JM, Contreras JL, Smyth CA, Lobashevsky A, Jenkins S, Hubbard WJ, Eckhoff DE, Stavrou S, Neville DM Jr, Thomas FT. Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes 2001;50:1227-36.
88. Luzi L, Hering BJ, Socci C, Raptis G, Battezzati A, Terruzzi I, Falqui L, Brandhorst H, Brandhorst D, Regalia E, Brambilla E, Secchi A, Perseghin G, Maffi P, Bianchi E, Mazzaferro V, Gennari L, Di Carlo V, Federlin K, Pozza G, Bretzel RG. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996;97:2611-8.
89. Ryan EA, Lakey JRT, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AMJ. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710-9.
90. Bertuzzi F, Grohovaz F, Maffi P, Caumo A, Aldrighetti L, Nano R, Hengster P, Calori G, Di Carlo V, Bonifacio E, Secchi A. Successful transplantation of human islets in recipients bearing a kidney graft. Diabetologia 2002;45:77-84.
91. Luzi L, Perseghin G, Brendel MD, Terruzzi I, Battezzati A, Eckhard M, Brandhorst D, Brandhorst H, Friemann S, Socci C, Di Carlo V, Piceni Sereni L, Benedini S, Secchi A, Pozza G, Bretzel RG. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 2001;50:277-82.
92. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counter-regulation or symptom recognition after insulin independence. Diabetes 2002;51:3428-34.
93. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, Venturini M, Socci C, Davalli A, Orsenigo E, Monti L, Falqui L, Uccella S, La Rosa S, Usellini L, Properzi G, Di Carlo V, Del Maschio A, Capella C, Secchi A. Long-term beneficial effect of islet transplantation on diabetic macro/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 2003;26:1129-36.